| |
---|
| Detailed Price Information Link |
PLASMIDS | |
Name: | pC194 |
DSM No.: | 4393 dsm-4393 dsm4393 dsm 4393 pC194 |
History: | <- S.D. Ehrlich |
Mol. weight: | 2.91 kb |
Marker: | Cmr |
Remarks: | Originally isolated from Staphylococcus aureus; sequence known; inducible Cm resistance; use: the resistance gene, which is expressed in E. coli, has been used in B. subtilis/E. coli shuttle vectors and in integrative plasmids used to map cloned B. subtilis genes. |
Distributed in: | Bacillus subtilis subsp. subtilis SB202 (derivative of strain 168) |
Cultivation conditions: | Medium 381, 30°C |
Literature: | 3169, 3170, 3171 |
Risk group: | 1 (classification according to German TRBA) |
Restrictions: | no |
Country: | country of origin unknown |
Date of sampling: | before 16.03.1990 |
Nagoya Protocol Restrictions: | There are NO known Nagoya protocol restrictions for this strain. |
Supplied as: | Delivery form | | Organization type | | | | Profit | | Non-Profit | | | Freeze Dried | | 100,- € | | 100,- € | | Active culture on request | | 240,- € | | 240,- € | |
Price category 1 strain. Please see price list for freight and handling charges |
| Print data sheet |